Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Triple Negative Breast Neoplasms × Urine Specimen Collection × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 2 Neoplasms 2 Lung Neoplasms 2 Carcinoma, Renal Cell 2 Weight Loss 1 Triple Negative Breast Neoplasms 1 Sleep Apnea Syndromes 1 Sezary Syndrome 1 Sarcoma 1 Overweight 1 Obesity, Morbid 1 Obesity 1 Non-Muscle Invasive Bladder Neoplasms 1 Mycosis Fungoides 1 Multiple Myeloma 1 Lymphoma, T-Cell, Cutaneous 1 Hypertension 1 Hyperlipidemias 1 Hemangioma 1 Gastroesophageal Reflux 1 Eczema 1 Digestive System Diseases 1 Diabetes Mellitus, Type 2 1 Diabetes Mellitus 1 Dermatitis, Atopic 1 Collagen Diseases 1 Breast Neoplasms 1

Interventions

Blood Specimen Collection 4 Drug Therapy 3 Specimen Handling 2 Immune Checkpoint Inhibitors 2 Carboplatin 2 Biopsy, Large-Core Needle 2 Biopsy 2 toripalimab 1 tislelizumab 1 taxane 1 sacituzumab govitecan 1 pembrolizumab 1 atezolizumab 1 Zoledronic Acid 1 Urine Specimen Collection 1 Prophylactic Mastectomy 1 Paracentesis 1 Neuropsychological Tests 1 Mifepristone 1 Medicine, Chinese Traditional 1 Mastectomy, Segmental 1 Magnetic Resonance Spectroscopy 1 Magnetic Resonance Imaging 1 Interviews as Topic 1 Immunotherapy 1 Immunohistochemistry 1 Gene Expression Profiling 1 Doxorubicin 1 DNA 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04268693 2022-11-17

EDC-TNBC

George Washington University

Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡